U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 53

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr3:8787262
GRCh38:
Chr3:8745576
OXTR, CAV3D55ECaveolinopathy, Long QT syndromeUncertain significance
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr3:8788211
GRCh38:
Chr3:8746525
CAV3, OXTRHypertrophic cardiomyopathy 1, Rippling muscle disease 2, Distal myopathy, Tateyama type,
Elevated circulating creatine kinase concentration, Long QT syndrome 9, Caveolinopathy
Uncertain significance
(Aug 20, 2021)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr3:8788151
GRCh38:
Chr3:8746465
CAV3, OXTRCaveolinopathyBenign
(Apr 27, 2017)
criteria provided, single submitter
4.
GRCh37:
Chr3:8788122
GRCh38:
Chr3:8746436
CAV3, OXTRCaveolinopathyBenign
(Jan 12, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr3:8787994
GRCh38:
Chr3:8746308
OXTR, CAV3Hypertrophic cardiomyopathy 1, Rippling muscle disease 2, Distal myopathy, Tateyama type,
Elevated circulating creatine kinase concentration, Long QT syndrome 9, Caveolinopathy
Uncertain significance
(Sep 13, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr3:8787993
GRCh38:
Chr3:8746307
CAV3, OXTRCaveolinopathyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr3:8787988
GRCh38:
Chr3:8746302
CAV3, OXTRCaveolinopathyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr3:8787893
GRCh38:
Chr3:8746207
CAV3, OXTRCaveolinopathy, not providedBenign
(Jan 13, 2018)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr3:8787865
GRCh38:
Chr3:8746179
CAV3, OXTRCaveolinopathyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr3:8787746
GRCh38:
Chr3:8746060
CAV3, OXTRCaveolinopathyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr3:8787687
GRCh38:
Chr3:8746001
OXTR, CAV3Hypertrophic cardiomyopathy 1, Rippling muscle disease 2, Distal myopathy, Tateyama type,
Elevated circulating creatine kinase concentration, Long QT syndrome 9, Caveolinopathy
Uncertain significance
(Sep 6, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr3:8787639
GRCh38:
Chr3:8745953
CAV3, OXTRCaveolinopathy, not providedConflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
13.
GRCh37:
Chr3:8787591
GRCh38:
Chr3:8745905
CAV3, OXTRCaveolinopathy, not providedBenign
(Apr 27, 2017)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr3:8787573
GRCh38:
Chr3:8745887
CAV3, OXTRCaveolinopathy, not specified, not provided
Benign
(Aug 6, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr3:8787566
GRCh38:
Chr3:8745880
CAV3, OXTRCaveolinopathyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr3:8787638
GRCh38:
Chr3:8745952
CAV3, OXTRCaveolinopathy, not specifiedConflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr3:8788406
GRCh38:
Chr3:8746720
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr3:8788405
GRCh38:
Chr3:8746719
CAV3, OXTRRippling muscle disease 2, Elevated circulating creatine kinase concentration, Hypertrophic cardiomyopathy 1,
Distal myopathy, Tateyama type, Long QT syndrome 9, Caveolinopathy,
Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome
Uncertain significance
(Sep 16, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr3:8788387
GRCh38:
Chr3:8746701
CAV3, OXTRRippling muscle disease 2, Elevated circulating creatine kinase concentration, Hypertrophic cardiomyopathy 1,
Distal myopathy, Tateyama type, Long QT syndrome 9, Caveolinopathy,
Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome
Uncertain significance
(Sep 21, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr3:8788364
GRCh38:
Chr3:8746678
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not provided,
Caveolinopathy
Benign/Likely benign
(Sep 10, 2021)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr3:8788358
GRCh38:
Chr3:8746672
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not provided,
Caveolinopathy
Conflicting interpretations of pathogenicity
(Oct 14, 2021)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr3:8788341
GRCh38:
Chr3:8746655
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr3:8788316
GRCh38:
Chr3:8746630
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr3:8788294
GRCh38:
Chr3:8746608
CAV3, OXTRRippling muscle disease 2, Elevated circulating creatine kinase concentration, Hypertrophic cardiomyopathy 1,
Distal myopathy, Tateyama type, Long QT syndrome 9, Caveolinopathy,
Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome
Uncertain significance
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr3:8788278
GRCh38:
Chr3:8746592
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Long QT syndrome,
Caveolinopathy, Hypertrophic cardiomyopathy
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
26.
GRCh37:
Chr3:8788275
GRCh38:
Chr3:8746589
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr3:8788145
GRCh38:
Chr3:8746459
CAV3, OXTRRippling muscle disease 2, Elevated circulating creatine kinase concentration, Hypertrophic cardiomyopathy 1,
Distal myopathy, Tateyama type, Long QT syndrome 9, Caveolinopathy,
Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome
Uncertain significance
(Oct 12, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr3:8788020
GRCh38:
Chr3:8746334
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr3:8787986
GRCh38:
Chr3:8746300
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr3:8787830
GRCh38:
Chr3:8746144
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr3:8787829
GRCh38:
Chr3:8746143
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not provided,
Caveolinopathy
Benign/Likely benign
(Jan 13, 2018)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr3:8787356
GRCh38:
Chr3:8745670
CAV3, OXTRL87FLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, Caveolinopathy
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr3:8787539
GRCh38:
Chr3:8745853
CAV3, OXTRR148Wnot specified, not provided, Cardiomyopathy,
Long QT syndrome, Caveolinopathy
Conflicting interpretations of pathogenicity
(Sep 1, 2021)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr3:8775530
GRCh38:
Chr3:8733844
CAV3Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not specified,
Caveolinopathy
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr3:8787298
GRCh38:
Chr3:8745612
CAV3, OXTRCardiovascular phenotype, not specified, not provided,
Caveolinopathy, Long QT syndrome
Conflicting interpretations of pathogenicity
(Apr 4, 2023)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr3:8787540
GRCh38:
Chr3:8745854
CAV3, OXTRR148QCardiovascular phenotype, Caveolinopathy, not provided,
Cardiomyopathy, not specified, Long QT syndrome
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr3:8787433
GRCh38:
Chr3:8745747
CAV3, OXTRHypertrophic cardiomyopathy 1, Distal myopathy, Tateyama type, Rippling muscle disease 2,
Long QT syndrome 9, Elevated circulating creatine kinase concentration, Cardiovascular phenotype,
not specified, not provided, Cardiomyopathy,
Caveolinopathy, Long QT syndrome ...see more
Benign/Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr3:8787373
GRCh38:
Chr3:8745687
CAV3, OXTRCardiovascular phenotype, not specified, not provided,
Long QT syndrome, Caveolinopathy, Cardiomyopathy
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr3:8787514
GRCh38:
Chr3:8745828
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Cardiovascular phenotype, Congenital long QT syndrome,
not provided, Long QT syndrome, Caveolinopathy,
Cardiomyopathy
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr3:8775526
GRCh38:
Chr3:8733840
CAV3Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not specified,
Caveolinopathy
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr3:8788336
GRCh38:
Chr3:8746650
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not provided,
Caveolinopathy
Benign/Likely benign
(May 10, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr3:8788096
GRCh38:
Chr3:8746410
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not provided,
Caveolinopathy
Benign/Likely benign
(May 10, 2021)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr3:8787220
GRCh38:
Chr3:8745534
CAV3, OXTRCardiovascular phenotype, Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome,
not specified, Caveolinopathy, Long QT syndrome
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr3:8775589
GRCh38:
Chr3:8733903
CAV3Limb-Girdle Muscular Dystrophy, Dominant, Cardiovascular phenotype, Distal myopathy, Tateyama type,
Rippling muscle disease 2, not specified, Congenital long QT syndrome,
not provided, Long QT syndrome, Caveolinopathy
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr3:8787268
GRCh38:
Chr3:8745582
CAV3, OXTRCardiovascular phenotype, Limb-Girdle Muscular Dystrophy, Dominant, not specified,
not provided, Long QT syndrome, Caveolinopathy,
Cardiomyopathy
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr3:8787301
GRCh38:
Chr3:8745615
CAV3, OXTRCardiovascular phenotype, not specified, not provided,
Cardiomyopathy, Long QT syndrome, Caveolinopathy
Benign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr3:8775661
GRCh38:
Chr3:8733975
CAV3Cardiovascular phenotype, Limb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome,
not specified, Caveolinopathy, Long QT syndrome,
not provided
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr3:8788364
GRCh38:
Chr3:8746678
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not provided,
Caveolinopathy
Benign/Likely benign
(May 10, 2021)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr3:8788198
GRCh38:
Chr3:8746512
CAV3, OXTRLimb-Girdle Muscular Dystrophy, Dominant, Congenital long QT syndrome, not provided,
Caveolinopathy
Benign/Likely benign
(May 10, 2021)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr3:8787330
GRCh38:
Chr3:8745644
CAV3, OXTRT78MCardiovascular phenotype, Long QT syndrome, not specified,
not provided, Caveolinopathy, Cardiomyopathy,
Long QT syndrome 9, Long QT syndrome 1
Conflicting interpretations of pathogenicity
(Jul 24, 2023)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr3:8787288
GRCh38:
Chr3:8745602
CAV3, OXTRT64SCaveolinopathyUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
52.
GRCh37:
Chr3:8787313
GRCh38:
Chr3:8745627
CAV3, OXTRC72WCardiovascular phenotype, Long QT syndrome, not provided,
not specified, Limb-girdle muscular dystrophy, Caveolinopathy,
Cardiomyopathy, Long QT syndrome 1
Conflicting interpretations of pathogenicity
(Aug 22, 2023)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr3:8787263
GRCh38:
Chr3:8745577
CAV3, OXTRG56SLong QT syndrome 9, Hypertrophic cardiomyopathy 1, Distal myopathy, Tateyama type,
Rippling muscle disease 2, Elevated circulating creatine kinase concentration, Cardiovascular phenotype,
Limb-Girdle Muscular Dystrophy, Dominant, Long QT syndrome, not specified,
Limb-girdle muscular dystrophy, CardiomyopathyCaveolinopathy,
not provided, Long QT syndrome 1, ...see more
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination